Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Entobel is a Biotechnology Research brand in Singapore. Ownership is privately held; it publishes at entobel.com. The record carries two addresses across two office countries. The record counts 59 people. Its latest round on record is Series B, US$30.0M. It is listed alongside three similar brands, mostly in Food and Beverage Manufacturing.
Entobel is converting low value organic substrate into high quality products thanks to insects.
Our main current products are sustainable animal feed (proteins and oils) and organic fertilizer.
Since 2013, Entobel is running a commercial scale production site in Vietnam and exporting products worldwide.
Entobel complies with highest standards in the industry (ISO 22000), only use tracable feedstocks and is FDA approved.
Entobel is looking for strong partners to join for its expansion plans. Don't hesitate to contact us for more information.
| Countries | 2 |
|---|---|
| Primary country | SG |
All codes: SG VN
| Rounds | 5 |
|---|---|
| Axis | 2013 to 2026 |
| Series B · 9 Jun 2022 | US$ 30.0M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
The record holds 59 counted staff profiles at January 2026, inside the self-reported 51–200 band.
Two addresses on record across 2 countries. Primary: Singapore 051531.
Five rounds. Latest 9 June 2022: Series B, US$30,000,000, investor Mekong Capital.
19 profiles list Entobel as a peer — 93rd percentile in Biotechnology Research. It lists ten peers of its own. Skretting Vietnam and Sentara Group list it back.